Brooke LeVasseur is the CEO of AristaMD and has 20 years of leadership experience launching new, innovative healthcare products and solutions to payers and providers, including software and eConsult solutions. Throughout her career, Brooke has worked with numerous startups in a variety of capacities, including corporate and commercial strategy, marketing and new business creation. She brings a wealth of experience drawing from executive roles at Thomson Reuters, Veracyte and Sequenom, as well as an array of consultant roles at industry-leading investment and healthcare companies such as Kleiner Perkins Caufield & Byers, Versant Ventures, Illumina, Cypher Genomics and GRAIL.